The trade halt with India triggered "urgent measures to secure" pharmaceutical needs in Pakistan, a report said.

Pakistani health authorities have initiated "emergency preparedness" measures to secure pharmaceutical supplies in response ...

It’s about what is possible when innovation meets intention,” Mary Ogangwu, chief Operating officer of Codix Bio, said at a press briefing in Lagos. Access to timely and accurate diagnostics remains a ...

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in ...

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...

Where thousands of former Health and Human Services employees will work next is unknown, but biopharma companies likely ...

We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

Duyk said the $30 million in funding has helped Grove Biopharma expand from "about four people working on this" to a current 10-person headcount and allowed it to move from Portal Innovation's labs to ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.